428 related articles for article (PubMed ID: 36965984)
21. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018.
Cotte L; Hocqueloux L; Lefebvre M; Pradat P; Bani-Sadr F; Huleux T; Poizot-Martin I; Pugliese P; Rey D; Cabié A;
Clin Infect Dis; 2021 Nov; 73(9):e3266-e3274. PubMed ID: 33400777
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of an HCV elimination program targeting the Viennese MSM population.
Jachs M; Binter T; Chromy D; Schalk H; Pichler K; Bauer D; Simbrunner B; Hartl L; Schmidbauer C; Mayer F; Strassl R; Mandorfer M; Gschwantler M; Reiberger T
Wien Klin Wochenschr; 2021 Jul; 133(13-14):635-640. PubMed ID: 34181068
[TBL] [Abstract][Full Text] [Related]
23. Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.
Boerekamps A; van den Berk GE; Lauw FN; Leyten EM; van Kasteren ME; van Eeden A; Posthouwer D; Claassen MA; Dofferhoff AS; Verhagen DWM; Bierman WF; Lettinga KD; Kroon FP; Delsing CE; Groeneveld PH; Soetekouw R; Peters EJ; Hullegie SJ; Popping S; van de Vijver DAMC; Boucher CA; Arends JE; Rijnders BJ
Clin Infect Dis; 2018 Apr; 66(9):1360-1365. PubMed ID: 29186320
[TBL] [Abstract][Full Text] [Related]
24. Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?
Garvey LJ; Cooke GS; Smith C; Stingone C; Ghosh I; Dakshina S; Jain L; Waters LJ; Mahungu T; Ferro F; Sood C; Freeman C; Phillips C; Dhairyawan R; Burholt R; Sharp H; Ullah S; Gilleece Y; Brown A; Orkin C; Rodger A; Bhagani S
Clin Infect Dis; 2021 Jan; 72(2):233-238. PubMed ID: 32211763
[TBL] [Abstract][Full Text] [Related]
25. Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study.
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV
Clin Infect Dis; 2020 Sep; 71(6):1502-1510. PubMed ID: 31585005
[TBL] [Abstract][Full Text] [Related]
26. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
[TBL] [Abstract][Full Text] [Related]
27. Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis.
Marquez LK; Ingiliz P; Boesecke C; Krznaric I; Schewe K; Lutz T; Mauss S; Christensen S; Rockstroh JK; Jain S; He F; Wertheim JO; Martin NK
PLoS One; 2022; 17(5):e0267853. PubMed ID: 35551326
[TBL] [Abstract][Full Text] [Related]
28. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Carrat F; Fontaine H; Dorival C; Simony M; Diallo A; Hezode C; De Ledinghen V; Larrey D; Haour G; Bronowicki JP; Zoulim F; Asselah T; Marcellin P; Thabut D; Leroy V; Tran A; Habersetzer F; Samuel D; Guyader D; Chazouilleres O; Mathurin P; Metivier S; Alric L; Riachi G; Gournay J; Abergel A; Cales P; Ganne N; Loustaud-Ratti V; D'Alteroche L; Causse X; Geist C; Minello A; Rosa I; Gelu-Simeon M; Portal I; Raffi F; Bourliere M; Pol S;
Lancet; 2019 Apr; 393(10179):1453-1464. PubMed ID: 30765123
[TBL] [Abstract][Full Text] [Related]
30. Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations.
Sun HY; Liu WD; Wang CW; Wei YJ; Lin KY; Huang YS; Su LH; Chen YT; Liu WC; Su YC; Chen YW; Chuang YC; Lu PL; Hung CC; Yu ML
Microbiol Spectr; 2022 Jun; 10(3):e0034522. PubMed ID: 35579445
[TBL] [Abstract][Full Text] [Related]
31. Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections.
Sun HY; Cheng CY; Lin CY; Yang CJ; Lee NY; Liou BH; Tang HJ; Liu YM; Lee CY; Chen TC; Huang YC; Lee YT; Tsai MJ; Lu PL; Tsai HC; Wang NC; Hung TC; Cheng SH; Hung CC
World J Gastroenterol; 2022 Mar; 28(11):1172-1183. PubMed ID: 35431505
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.
Bregenzer A; Bruggmann P; Castro E; Moriggia A; Rothen M; Thurnheer MC; Vernazza P; Scheidegger C
Swiss Med Wkly; 2021 Mar; 151():w20460. PubMed ID: 33705563
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020.
Harney BL; Sacks-Davis R; van Santen DK; Traeger MW; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews GV; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS
Liver Int; 2024 Apr; 44(4):1024-1031. PubMed ID: 38291946
[TBL] [Abstract][Full Text] [Related]
34. Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?
Martin NK; Boerekamps A; Hill AM; Rijnders BJA
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25062. PubMed ID: 29633560
[TBL] [Abstract][Full Text] [Related]
35. Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies.
Iversen J; Wand H; McManus H; Dore GJ; Maher L
Addiction; 2023 May; 118(5):901-911. PubMed ID: 36524842
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis C virus infection among men who have sex with men with human immunodeficiency virus-1 infection between 2010 and 2020 in Japan: A single-center retrospective cohort study.
Nishikawa K; Kimura M; Imamura J; Kimura K
J Infect Chemother; 2023 Mar; 29(3):263-268. PubMed ID: 36585274
[TBL] [Abstract][Full Text] [Related]
37. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?
Gómez-Ayerbe C; Palacios R; Ríos MJ; Téllez F; Sayago C; Martín-Aspas A; Camacho A; Muñoz L; Santos J;
Int J STD AIDS; 2021 Nov; 32(13):1257-1260. PubMed ID: 34293985
[TBL] [Abstract][Full Text] [Related]
38. Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?
Bischoff J; Boesecke C; Ingiliz P; Berger F; Simon KG; Lutz T; Schewe CK; Schulze Zur Wiesch J; Hueppe D; Christensen S; Mauss S; Baumgarten A; Rockstroh JK;
J Clin Gastroenterol; 2020 Feb; 54(2):192-199. PubMed ID: 30789853
[TBL] [Abstract][Full Text] [Related]
39. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and Clinical Manifestations of Acute Hepatitis C Infection in People Living with HIV.
O'Shea J; Oliver N; Cartwright EJ
AIDS Patient Care STDS; 2022 May; 36(5):172-177. PubMed ID: 35507325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
